We are committed to providing affordable, high-quality new antiviral drugs
JKT BioPharma Co., Ltd. is a new specialty pharmaceutical enterprise jointly established by the listed company JoinTown Pharmaceutical Group Co., Ltd. (600998) and Convalife (Shanghai) Co., LTD. The company focuses itself in the development and commercialization of innovative drugs for infectious diseases, and is committed to providing affordable and high-quality new treatment solutions for patients in China and around the world.
JKT BioPharma Co., Ltd. adopts the "3I" strategy (Innovation, Integration and Internationalization). By combining the strength of Wuhan Institute of Virology and Shanghai Institute of Materia Medica (Chinese Academy of Sciences) in new drug R&D, and by making full use of the well-established commercial channels from JoinTown Pharmaceutical Group, JKT BioPharma will be able to ensure accessibility of the public to more and more innovative drugs, and to bring drug innovation and services in China to a higher level.
2022
JKTIt was founded in 2022
10million
JKTRegistered capital
4companies
JKTAssociation of enterprises